Please use this identifier to cite or link to this item: http://hdl.handle.net/1942/9847
Full metadata record
DC FieldValueLanguage
dc.contributor.authorJanssen, Sofie P. M.-
dc.contributor.authorPhernambucq, Marko-
dc.contributor.authorMartinez-Martinez, Pilar-
dc.contributor.authorDE BAETS, Marc-
dc.contributor.authorLosen, Mario-
dc.date.accessioned2009-08-31T14:19:15Z-
dc.date.available2009-08-31T14:19:15Z-
dc.date.issued2008-
dc.identifier.citationJOURNAL OF NEUROIMMUNOLOGY, 201. p. 111-120-
dc.identifier.issn0165-5728-
dc.identifier.urihttp://hdl.handle.net/1942/9847-
dc.description.abstractCurrently used non-specific immunosuppresive drugs often require intervention in myasthenia gravis (MG) and clinical improvement varies widely. To analyze the therapeutic effect of mycophenolate mofetil (MMF) in experimental autoimmune MG (EAMG), rats were immunized with acetylcholine receptors (AChRs) and subsequently treated with MMF or vehicle. MMF treatment resulted in a significant suppression of anti-rat AChR antibody titers. Interestingly, no abnormalities of neuromuscular transmission and adverse side effects were detected in MMF-treated EAMG animals. Moreover, anti-rat AChR antibody titers correlated to an improvement of clinical outcome. In conclusion, our data suggest that MMF acts as a potent immunosuppressant drug in EAMG. (C) 2008 Elsevier B.V All rights reserved.-
dc.language.isoen-
dc.publisherELSEVIER SCIENCE BV-
dc.subject.otherMyasthenia gravis; Mycophenolate mofetil; Immunosuppression; Acetylcholine receptor; Neuromuscular junction-
dc.titleImmunosuppression of experimental autoimmune myasthenia gravis by mycophenolate mofetil-
dc.typeJournal Contribution-
dc.identifier.epage120-
dc.identifier.spage111-
dc.identifier.volume201-
local.format.pages10-
local.bibliographicCitation.jcatA1-
dc.description.notes[Janssen, Sofie P. M.; Phernambucq, Marko; Martinez-Martinez, Pilar; De Baets, Marc H.; Losen, Mario] Maastricht Univ, Fac Hlth Med & Life Sci, Sch Mental Hlth & Neurosci, Dept Neurosci, NL-6200 MD Maastricht, Netherlands. [De Baets, Marc H.] Hasselt Univ, Biomed Res Inst BIOMED, Neuroimmunol Grp, Diepenbeek, Belgium.-
local.type.refereedRefereed-
local.type.specifiedArticle-
dc.bibliographicCitation.oldjcatA1-
dc.identifier.doi10.1016/j.jneuroim.2008.05.029-
dc.identifier.isi000260294800018-
item.accessRightsOpen Access-
item.contributorJanssen, Sofie P. M.-
item.contributorPhernambucq, Marko-
item.contributorMartinez-Martinez, Pilar-
item.contributorDE BAETS, Marc-
item.contributorLosen, Mario-
item.fullcitationJanssen, Sofie P. M.; Phernambucq, Marko; Martinez-Martinez, Pilar; DE BAETS, Marc & Losen, Mario (2008) Immunosuppression of experimental autoimmune myasthenia gravis by mycophenolate mofetil. In: JOURNAL OF NEUROIMMUNOLOGY, 201. p. 111-120.-
item.fulltextWith Fulltext-
item.validationecoom 2009-
crisitem.journal.issn0165-5728-
crisitem.journal.eissn1872-8421-
Appears in Collections:Research publications
Files in This Item:
File Description SizeFormat 
Janssen.pdfPublished version836.8 kBAdobe PDFView/Open
Show simple item record

SCOPUSTM   
Citations

17
checked on Sep 2, 2020

WEB OF SCIENCETM
Citations

17
checked on Sep 28, 2024

Page view(s)

68
checked on Sep 7, 2022

Download(s)

234
checked on Sep 7, 2022

Google ScholarTM

Check

Altmetric


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.